|
|
List of sponsors 
If you are interested in sponsorship opportunities at this event then please contact:
Edward Low, Project Manager
Email: edward.low@terrapinn.com
Tel: 0207 827 5994
Fax: 0207 242 1508
|
Gold sponsor
|
Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification, especially in the biopharmaceutical industry for the production of biotech and biopharmaceutical products.
Pall's Life Sciences Group is fully integrated to offer product lines that start in the laboratory with drug discovery, gene manipulation and proteomics applications, and extend into drug development, process scale up, through to full drug manufacturing production and patient delivery. Pall's extensive expertise helps its customers throughout the drug approval regulatory process, and its filtration systems and validation services offer drug manufacturers the quickest and surest path through the regulatory process and onto the market. As Mr Jerold M. Martin, Senior Vice President and Global Technical Director for Pall Life Sciences' BioPharmaceuticals division said, "Pall Corporation is committed to developing the most advanced, cost-effective virus filtration products that maximize customers' opportunity for success."
|
|
Silver sponsor
|
AVANT Immunotherapeutics, Inc. discovers, develops and sells innovative vaccines and therapeutics that harness the human immune system to prevent and treat disease. The company has developed a broad, well-staged pipeline of vaccines and therapeutics for under-served markets. Three of AVANT’s products are marketed, including two food safety vaccines and our partner GlaxoSmithKline’s oral rotavirus vaccine, Rotarix®, which GSK is launching worldwide. Six of AVANT’s products are in clinical development, including vaccines that protect against important disease causing agents, a treatment to reduce complement-mediated tissue damage associated with cardiac bypass surgery and a novel vaccine for cholesterol management. AVANT has assembled a technology platform that enables the creation of rapid-protecting, single-dose, oral vaccines that remain temperature stable. The company is developing applications of this vaccine technology in four areas: biodefense, travelers’ vaccines, global health needs, and human food safety. Further, AVANT has established a state-of-the-art vaccine manufacturing facility for the production of its vaccines. AVANT’s goal is to demonstrate proof-of-concept for its products before leveraging further development through both traditional pharmaceutical partnerships and collaborations with governmental and other organizations. Our goal is to become a leading developer of innovative vaccines that address health care needs on a global basis.
|
As the worldwide leader in clinical research, Quintiles has in-depth expertise in vaccines and an exceptional track record: since 2000, we have conducted 70 vaccine studies involving more than 144,000 patients in 56 countries. Our experience spans Phases I-IV studies in the prevention of influenza, HIV, hepatitis, pneumococcal, pertussis, RSV, anthrax, plague, smallpox, melanoma, and many other vaccine areas. Worldwide, you can count on Quintiles to deliver the results you need. Visit us at www.quintiles.com.
|
Synco BioPartners is one of Europes leading Contract Manufacturing Organizations. Focusing exclusively on Biopharmaceuticals and Vaccines, Synco offers a complete range of manufacturing services including fermentation development, downstream process development, assay development and CGMP manufacture for Phase I-III clinical trials and market supply. Synco also offers a filling and lyophilization service, again to CGMP. Synco has an extensive track record of succesful manufacturing project, and is currently engaged in the manufacture of APIs for clinical trials and for European market supply.
|
|
Lunch sponsor
|
Dowpharma(SM) is a business unit of The Dow Chemical Company, serving the pharmaceutical and biopharmaceutical industries. Innovative technologies feature Pfenex Expression Technology (TM), pegylation, and chiral technologies including asymmetric hydrogenation, asymmetric hydoformylation, biocatalysis, chiral separation, and multi-step synthesis.
|
|
|
|
